An estimated one in five pregnant women around the world carry Group B Streptococcus (GBS) bacteria which is a major, yet preventable, cause of maternal and infant ill health globally. These are the findings...

Pfizer Inc. announced that it has started a Phase 1 trial in healthy volunteers of PF-06760805, an investigational vaccine designed to help protect against Group B Streptococcus (GBS) infection. In newborns,...

By

In a study by Dutch researchers from the Reference Laboratory for Bacterial Meningitis in Amsterdam, they find that current practices of only offering antibiotic treatment during labor to pregnant women...

This is suggested in a study in the journal PLoS One. A team of researchers from Michigan State University published finding that Group B streptococcus may be a zoonotic disease, transmitted from cows...